All Blog Posts

Explore the role of primary antibodies targeting CD proteins in neurobiology and cancer research. Read more to discover how these antibodies facilitate precise cell population identification in the nervous system and contribute to human cancer disease diagnosis and prognosis.

Explore the importance of new biomarkers in glioma research and their potential to revolutionize diagnosis, prognosis, and treatment of this aggressive brain tumor. Discover new emerging biomarkers that will help to enhance patient outcomes and guide personalized therapeutic strategies.

The British Neuroscience Association (BNA) hosted its 6th International Festival of Neuroscience in April. Atlas Antibodies was there promoting his catalog of primary antibodies for Neuroscience research. Were you also there? Here we briefly summarise the exciting lectures we attended this year.

Biomarkers are measurable biological indicators with numerous clinical applications each providing unique information about an individual's health status. The identification and development of new biomarkers can greatly improve disease detection, prognosis, and treatment. There are seven categories of clinical applications of biomarkers, each with a unique purpose and significance. Learn more!

Understanding the development and progression of lineage cell types within the nervous system is critical for understanding the mechanisms of neurodegeneration and other brain diseases and can help identify potential sites for intervention. Read more and explore our primary antibodies targeting relevant markers in the neural lineage development pathways.

Good stuff is worth sharing! 2022. In 12 blog posts, we have opened our doors to you with a multitude of ideas, interactions, and support flowing in. To our incredible community of customers and contributors, we say Thank You!

A neuroendocrine neoplasm (NEN) begins in the cells of the neuroendocrine system. These cells have traits of both hormone-producing endocrine cells and nerve cells. The advent of second-generation NEN markers for use in immunohistochemistry has considerably expanded the pathology toolbox for diagnosing and classifying NENs. Atlas Antibodies has released new monoclonal markers targeting NENs. Read more in our new blog post!

Meet Ava Zakizadeh, Lab Engineer at Atlas Antibodies. This year was full of success for her as she was awarded by colleagues and recently got promoted. Colleagues describe her as approachable, open to cross-functional collaboration, and helpful at any time, always going the extra mile. They also say that she always contributes to a caring and fun environment in teams and meetings. Find out more about her journey in this interview.

Chiara Musillo, a Ph.D. student from La Sapienza University of Rome, Italy, won the first Atlas Antibodies’ travel grant competition to attend the FENS Forum 2022 in Paris, held in July. Our scientists at Atlas Antibodies selected her research project among many good applications. Here is her story in her own words.

In the last three years, our company has given opportunities to Master’s students to join 20 weeks program and do their thesis. Since then, five students used that chance and after they finished the program, they were usually offered a job in Atlas Antibodies. Here is one of those stories.